A Newer Class of Migraine Drugs Is Linked to a 40% Rise in Miscarriage Risk
(Thai Noipho/iStockphoto/Getty Images) "Further research is needed to evaluate their safety during pregnancy." Don't miss a story, subscribe here.
We haven't written up this one. ScienceAlert has the full story — the link below goes straight to it.